The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!
The old advanced search is still avaliable.
New Features:
| Title | FOA Number | Organization | Released | Expires | Activity Code |
| Pre-application for a Biomedical Technology Research Resource (X02) | PAR-17-315 | NIGMS | 06-14-2017 | 03-16-2020 | X02 |
| Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01) | PAR-15-314 | NHLBI | 07-29-2015 | 06-16-2018 | X01 |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) | PAR-16-021 | NHLBI | 10-30-2015 | 10-19-2018 | X01 |
| Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) | PAR-17-269 | NHGRI | 05-03-2017 | 07-11-2020 | X01 |
| NIDDK Central Repositories Non-renewable Sample Access (X01) | PAR-17-270 | NIDDK | 05-03-2017 | 07-01-2020 | X01 |
| Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01) | PAR-17-458 | NIDA | 08-15-2017 | 11-01-2020 | X01 |
| Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional) | PAR-18-580 | NIAAA | 01-12-2018 | 12-05-2020 | UT2 |
| Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed) | RFA-AI-18-001 | NIAID | 02-07-2018 | 06-29-2018 | UM1 |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) | RFA-AI-18-003 | NIAID | 03-08-2018 | 06-23-2018 | UM1 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed | PAR-18-310 | NCI | 10-12-2017 | 10-09-2020 | UH3 |
| BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required) | RFA-NS-18-023 | NINDS | 12-21-2017 | 10-22-2020 | UH3 |
| Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3) | PAR-15-267 | NIDA | 05-26-2015 | 05-08-2018 | UH2/UH3 |
| Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional) | PAR-18-221 | NIDA | 11-29-2017 | 05-08-2018 | UH2/UH3 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) | PAR-18-317 | NCI | 10-12-2017 | 10-09-2020 | UH2/UH3 |
| Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2) | PAR-16-253 | NIAID | 05-10-2016 | 10-05-2018 | UH2 |
| Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3) | PAR-17-465 | NCATS | 08-21-2017 | 09-08-2020 | UH2 |
| New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3) | PAR-16-349 | NCI | 06-29-2016 | 04-17-2019 | UG3/UH3 |
| Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3) | PAR-17-128 | NCI | 01-19-2017 | 01-10-2020 | UG3/UH3 |
| Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional) | PAR-18-248 | NCI | 11-29-2017 | 01-10-2020 | UG3/UH3 |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) | PAR-18-268 | NIMH | 11-21-2017 | 10-25-2018 | UG3/UH3 |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required | PAR-18-407 | NHLBI | 10-25-2017 | 09-14-2019 | UG3/UH3 |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Required) | RFA-NS-18-011 | NINDS | 11-08-2017 | 10-22-2020 | UG3/UH3 |
| NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional) | RFA-DA-18-020 | NIDA | 12-06-2017 | 09-08-2020 | UG3/UH3 |
| Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional) | RFA-DA-19-002 | NIDA | 12-15-2017 | 01-02-2020 | UG3/UH3 |
| Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) | PAR-18-494 | NIDA | 12-15-2017 | 07-25-2020 | UG3/UH3 |
Latest News
Subscribe and Follow
Virtual Learning
Connect In Person
